ConductScience.org, home

Paper3501698

Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immune deficiency syndrome.

Yajko DM and 2 others. Antimicrob Agents Chemother, 1987. Cited by 54 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immune deficiency syndrome. Papers, record 3501698. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3501698

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immune deficiency syndrome.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1987
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
54
iCite
Relative citation ratio, by iCite
2.54
iCite
Revised in PubMed
2021-05-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yajko DMD M
2Nassos PSP S
3Hadley WKW K

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Acquired Immunodeficiency SyndromeMajor topic
Anti-Bacterial AgentsMajor topic
Mycobacterium aviumMajor topic
Culture Media
Humans
Microbial Sensitivity Tests
Polysorbates
beta-Lactamases

Source PubMed

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13,985,594Susceptibility of intra- and extracellular Mycobacterium avium-intracellulare to cephem antibiotics.Antimicrob Agents Chemother1985https://conductscience.org/library/papers/3985594PubMed
23,972,985
Infections caused by Mycobacterium avium complex in immunocompromised patients: diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics.
J Clin Microbiol1985https://conductscience.org/library/papers/3972985PubMed
32,996,410Treatment of infections in patients with the acquired immunodeficiency syndrome.Ann Intern Med1985https://conductscience.org/library/papers/2996410PubMed
44,073,865Comparative in vitro activities of MDL 473, rifampin, and ansamycin against Mycobacterium intracellulare.Antimicrob Agents Chemother1985https://conductscience.org/library/papers/4073865PubMed
54,073,881Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methods.Antimicrob Agents Chemother1985https://conductscience.org/library/papers/4073881PubMed
62,940,969Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/2940969PubMed
73,771,767Comparison of 15 laboratory and patient-derived strains of Mycobacterium avium for ability to infect and multiply in cultured human macrophages.J Clin Microbiol1986https://conductscience.org/library/papers/3771767PubMed
83,097,069Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth.J Clin Microbiol1986https://conductscience.org/library/papers/3097069PubMed
93,794,396Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.J Infect Dis1987https://conductscience.org/library/papers/3794396PubMed
103,032,086Therapeutic implications of inhibition versus killing of Mycobacterium avium complex by antimicrobial agents.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3032086PubMed
11879,732Permeability barrier to rifampin in mycobacteria.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/879732PubMed
127,339,819Basis for lack of drug susceptibility of atypical mycobacteria.Rev Infect Dis1981https://conductscience.org/library/papers/7339819PubMed
136,289,711In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin.Am Rev Respir Dis1982https://conductscience.org/library/papers/6289711PubMed
146,524,901Intra- and extracellular susceptibility of Mycobacterium avium-intracellulare complex to aminoglycoside antibiotics.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6524901PubMed
154,004,193Morphological changes induced by beta-lactam antibiotics in Mycobacterium avium-intracellulare complex.Antimicrob Agents Chemother1985https://conductscience.org/library/papers/4004193PubMed

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMIDTitleJournalYearIn PapersSource
38,150,401Oral β-Lactam Pairs for the Treatment of Mycobacterium avium Complex Pulmonary Disease.J Infect Dis2024https://conductscience.org/library/papers/38150401PubMed
38,036,299Ceftriaxone Efficacy for Mycobacterium avium Complex Lung Disease in the Hollow Fiber and Translation to Sustained Sputum Culture Conversion in Patients.J Infect Dis2024https://conductscience.org/library/papers/38036299PubMed
32,599,854Structural Modifications of 3-Triazeneindoles and Their Increased Activity Against Mycobacterium tuberculosis.Antibiotics (Basel)2020https://conductscience.org/library/papers/32599854PubMed
28,652,235Nifurtimox Is Ineffective against Drug-Resistant Mycobacteria.Antimicrob Agents Chemother2017https://conductscience.org/library/papers/28652235PubMed
15,931,343Growth, Congo Red agar colony morphotypes and antibiotic susceptibility testing of Mycobacterium avium subspecies paratuberculosis.Clin Med Res2004https://conductscience.org/library/papers/15931343PubMed
10,991,858Prediction of quinolone activity against Mycobacterium avium by molecular topology and virtual computational screening.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/10991858PubMed
10,582,897
Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
Antimicrob Agents Chemother1999https://conductscience.org/library/papers/10582897PubMed
8,913,479N-1-tert-butyl-substituted quinolones: in vitro anti-Mycobacterium avium activities and structure-activity relationship studies.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8913479PubMed
8,851,604In vitro activities of rifabutin, azithromycin, ciprofloxacin, clarithromycin, clofazimine, ethambutol, and amikacin in combinations of two, three, and four drugs against Mycobacterium avium.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8851604PubMed
8,843,278Susceptibility testing of Mycobacterium avium complex isolates.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8843278PubMed
8,432,816Comparison of four decontamination methods for recovery of Mycobacterium avium complex from stools.J Clin Microbiol1993https://conductscience.org/library/papers/8432816PubMed
8,408,551Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates.J Clin Microbiol1993https://conductscience.org/library/papers/8408551PubMed
8,358,707The Mycobacterium avium complex.Clin Microbiol Rev1993https://conductscience.org/library/papers/8358707PubMed
8,239,587Anti-Mycobacterium avium activity of quinolones: in vitro activities.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8239587PubMed
7,986,010In vitro anti-Mycobacterium avium activities of quinolones: predicted active structures and mechanistic considerations.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/7986010PubMed
7,872,747A bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditions.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/7872747PubMed
7,698,124Antimycobacterial susceptibility testing: present practices and future trends.Eur J Clin Microbiol Infect Dis1994https://conductscience.org/library/papers/7698124PubMed
7,535,036Pharmacokinetics, toxicity, and efficacy of liposomal capreomycin in disseminated Mycobacterium avium beige mouse model.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/7535036PubMed
3,196,000Antimicrobial synergism against Mycobacterium avium complex strains isolated from patients with acquired immune deficiency syndrome.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/3196000PubMed
2,808,669Differences in antimicrobial susceptibility of pigmented and unpigmented colonial variants of Mycobacterium avium.J Clin Microbiol1989https://conductscience.org/library/papers/2808669PubMed

See all 27 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3501698

GET https://conductscience.org/api/papers/v1/3501698/cited_by?page=2